Ask someone what a bone looks like and many people will think about a skeleton such as from biology class or a dinosaur skeleton in a museum. Perhaps that's because both are great visuals.
Thinking of those bones, however, can give the impression that bones are static and unchanging, like rock or marble. However, our bones are an amazing, living organ with tissue that continually remodels and rebuilds during our lifetimes. In fact, children replace their entire skeleton every 2 years. Even adults, after reaching skeletal maturity, continue to replace their skeleton every 7 years.
One reason that our bones are so active in remodeling is the stress our bodies go under, from exercise to trauma. Also, much like muscles, our bones get larger and stronger when used actively. Therefore, it's important to exercise our bones, particularly weight-bearing and muscle-building exercises.
There are numerous exercises of each type that can be beneficial. To learn more, call our office or visit the National Osteoporosis Foundation website for more information: Exercise for Healthy Bones | National Osteoporosis Foundation
Exploring a variety of options to bring back pain levels down from ten to zero without invasive surgery. Learn about causes of pain such as vertebral fractures, spinal stenosis, facet degeneration and the most effective technologies to treat them.
Saturday, September 25, 2010
Tuesday, June 8, 2010
New Osteoporosis Medication Approved By FDA
The US Food and Drug Administration(FDA) recently approved the first drug in a new class of osteoporosis-fighting medications known as RANKL, or RANK ligand inhibitors. These medications work decrease bone loss in a way that is different from other osteoporosis medications (such as Fosamax, Boniva, etc.)
The newly approved drug, denosumab (Prolia), is an injectable medication derived from a synthetic antibody. It is approved by the FDA for treating postmenopausal women with osteoporosis and other patients who have failed or couldn't tolerate other medications.
To learn more, call 260-9322.
The newly approved drug, denosumab (Prolia), is an injectable medication derived from a synthetic antibody. It is approved by the FDA for treating postmenopausal women with osteoporosis and other patients who have failed or couldn't tolerate other medications.
To learn more, call 260-9322.
Subscribe to:
Posts (Atom)
The Blogs I Read
All posts are copyright Musculoskeletal Imaging of Tulsa.